182 related articles for article (PubMed ID: 15081787)
1. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent.
Higgins GA; Ballard TM; Kew JN; Richards JG; Kemp JA; Adam G; Woltering T; Nakanishi S; Mutel V
Neuropharmacology; 2004 Jun; 46(7):907-17. PubMed ID: 15081787
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
[TBL] [Abstract][Full Text] [Related]
3. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
[TBL] [Abstract][Full Text] [Related]
4. Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.
Hanna L; Ceolin L; Lucas S; Monn J; Johnson B; Collingridge G; Bortolotto Z; Lodge D
Neuropharmacology; 2013 Mar; 66():114-21. PubMed ID: 22445601
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of either mGlu2 or mGlu3 receptors can induce LTD in the amygdala.
Lucas SJ; Bortolotto ZA; Collingridge GL; Lodge D
Neuropharmacology; 2013 Mar; 66():196-201. PubMed ID: 22531751
[TBL] [Abstract][Full Text] [Related]
6. Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata.
Johnson KA; Niswender CM; Conn PJ; Xiang Z
Neurosci Lett; 2011 Oct; 504(2):102-106. PubMed ID: 21945652
[TBL] [Abstract][Full Text] [Related]
7. Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses.
Robbe D; Alonso G; Chaumont S; Bockaert J; Manzoni OJ
J Neurosci; 2002 Jun; 22(11):4346-56. PubMed ID: 12040040
[TBL] [Abstract][Full Text] [Related]
8. Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo.
Linden AM; Bergeron M; Schoepp DD
Neuropharmacology; 2005; 49 Suppl 1():120-34. PubMed ID: 16023151
[TBL] [Abstract][Full Text] [Related]
9. Distinct properties of presynaptic group II and III metabotropic glutamate receptor-mediated inhibition of perforant pathway-CA1 EPSCs.
Capogna M
Eur J Neurosci; 2004 May; 19(10):2847-58. PubMed ID: 15147318
[TBL] [Abstract][Full Text] [Related]
10. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
12. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
[TBL] [Abstract][Full Text] [Related]
13. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus.
Mercier MS; Lodge D; Fang G; Nicolas CS; Collett VJ; Jane DE; Collingridge GL; Bortolotto ZA
Neuropharmacology; 2013 Apr; 67():294-303. PubMed ID: 23220400
[TBL] [Abstract][Full Text] [Related]
16. Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.
Hiyoshi T; Marumo T; Hikichi H; Tomishima Y; Urabe H; Tamita T; Iida I; Yasuhara A; Karasawa J; Chaki S
J Pharmacol Exp Ther; 2014 Dec; 351(3):642-53. PubMed ID: 25277141
[TBL] [Abstract][Full Text] [Related]
17. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
Tizzano JP; Griffey KI; Schoepp DD
Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
[TBL] [Abstract][Full Text] [Related]
18. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.
Gewirtz JC; Chen AC; Terwilliger R; Duman RC; Marek GJ
Pharmacol Biochem Behav; 2002 Sep; 73(2):317-26. PubMed ID: 12117585
[TBL] [Abstract][Full Text] [Related]
19. Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus.
Linden AM; Baez M; Bergeron M; Schoepp DD
Neuropharmacology; 2006 Aug; 51(2):213-28. PubMed ID: 16733060
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice.
Kew JN; Pflimlin MC; Kemp JA; Mutel V
Neuropharmacology; 2002 Aug; 43(2):215-21. PubMed ID: 12213275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
